ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell CarcinomaTomomi Kamba(Kumamoto University Hospital)Current Issues in Molecular BiologyDecember 2, 202410.3390/cimb46120817Cited by 3SaveCiteExport RISWatch citationsRelated PapersRole of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma|PLoS ONE|2015|44Fifth Joint Meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological Association|International Journal of Urology|2010|1